You are currently viewing a new version of our website. To view the old version click .

Management of National and Regional Immunization Programmes: Current Challenges and Future Strategies

This special issue belongs to the section “Vaccines and Public Health“.

Special Issue Information

Dear Colleagues,

In these challenging times of rising infection and cancer rates, particularly in low- and middle-income countries, it is essential that countries learn from each other in order to improve future access to vaccines and vaccination coverage where there are concerns across all target groups. As a result reduce future morbidity and mortality, including mortality due to antimicrobial resistance from inappropriate prescribing of antimicrobials. We welcome original research papers and reviews on these key topics, with insights and suggested ways forward for immunization programmes to enhance public health, including those for COVID-19. Topics of interest include, but are not limited to, issues and challenges surrounding vaccines, including vaccine hesitancy and vaccine uptake, strategies to address misinformation and build vaccine confidence, and key economic considerations, including affordability. Waivers and reduced publication fees will be available on request for a limited number of papers that will enhance this Special Issue, especially those from low- and low-middle income countries.

Prof. Dr. Johanna C Meyer
Dr. Sylvia Opanga
Prof. Dr. Brian Godman
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • COVID
  • challenges
  • vaccines
  • antimicrobials
  • public health

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X